A carregar...
Long‐term efficacy and safety of adjunctive extended‐release oxcarbazepine (Oxtellar XR(®)) in adults with partial‐onset seizures
OBJECTIVE: To evaluate long‐term outcomes of adjunctive therapy with SPN‐804 (Oxtellar XR(®), Supernus Pharmaceuticals), an extended‐release tablet formulation of oxcarbazepine (OXC), in adults with refractory partial‐onset seizures. METHODS: After completing a 16‐week double‐blind, placebo‐controll...
Na minha lista:
| Publicado no: | Acta Neurol Scand |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5042072/ https://ncbi.nlm.nih.gov/pubmed/26248506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ane.12467 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|